[INSERT TABLE 1]
Inferential Analysis
The clinical complications following pregnancy tissue expulsion were classified into different groups, and the data has been put together in Table-2. Mild to moderate post-abortion hemorrhage was treated with misoprostol accompanied by methylergometrine, and this group constituted the majority of the patients (83.3%), the only exception to this being two patients who reported acute painful misoprostol bleeding (more painful than severe menstrual cramps). Whereas, the groups that received misoprostol plus oxytocin and misoprostol alone complained of mild to severe pains, and constituted 80% and 73.3% of the study sample, respectively. Further, with regards to the distribution of bleeding onset, no statistical significance could be established (P=0.627) (Table2).
As for pain severity, the VAS score was compared in the three groups’ post-abortion and after medication misoprostol intake. The outcome for the three groups that comprised of those given misoprostol plus oxytocin, misoprostol plus methylergonovine and misoprostol alone, the median and first, second and third quantiles (percentiles of 25th, 50th, and 75th) were obtained [3 (interquartile range (IQR) of 2.75-5.25), 2 (IQR: 1.75-4) and 4.5 (IQR: 2.75-6)] with a P-value of 0.014, respectively (Figure 2). Notably, the median score of VAS in the group that received a compound of misoprostol plus methylergonovine was less than that of the group treated by misoprostol alone, with P=0.011. On the other hand, there was no evidence of a remarkable statistical significance in the median VAS score between those patients who received misoprostol plus methylergonovine and misoprostol plus oxytocin. Similar observations were reported in the group treated with combined therapy of oxytocin plus misoprostol and misoprostol alone, with P>0.05 (Table 2)